Vanguard Group Inc Pear Therapeutics, Inc. Transaction History

Vanguard Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.21 - $1.24 $149,614 - $883,438	712,450 Added 40.23%	2,483,472 $645,000
Q4 2022 Feb 10, 2023	SELL	$0.99 - $2.91 $1.44 Million - $4.24 Million	-1,455,445 Reduced 45.11%	1,771,022 $2.09 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $2.27 $281,028 - $4.91 Million	2,161,758 Added 203.04%	3,226,467 $6.58 Million
Q2 2022 Aug 12, 2022	BUY	$1.54 - $6.48 $29,669 - $124,843	19,266 Added 1.84%	1,064,709 $1.64 Million
Q1 2022 May 13, 2022	BUY	$3.67 - $7.63 $1.55 Million - $3.23 Million	422,804 Added 67.91%	1,045,443 $5.28 Million
Q4 2021 Feb 14, 2022	BUY	$4.98 - $10.0 $3.1 Million - $6.23 Million	622,639 New	622,639 $3.86 Million

23M

Ticker PEAR
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 138,768,992
Market Cap $1.39M
Description
Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a softwa...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.